Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Beasley

Showing results (51-60 of 443) with videos related to

Pageof 45
Sort By:
Lancet (London, England)|April 18, 2006
New look at the oxyhaemoglobin dissociation curveRichard Beasley, Amanda McNaughton, Geoffrey Robinson
Journal of the Royal Society of Medicine|November 2, 2005
Venous thromboembolism in medical inpatients--the silent epidemic of neglectKyle Perrin, Philip Robinson, Richard Beasley
Expert Review of Respiratory Medicine|October 22, 2013
Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?Mitesh Patel, Janine Pilcher, Richard Beasley
Respirology (Carlton, Vic.)|April 3, 2020
From Osler to personalized medicine in obstructive airways diseaseNethmi Kearns, Ciléin Kearns, Richard Beasley
Journal of Medical Economics|May 16, 2022
A breath of fresh AIR: reducing the carbon footprint of asthmaLee Hatter, Pepa Bruce, Richard Beasley
The European Respiratory Journal|June 20, 2024
The evidence base for ICS/formoterol maintenance and reliever therapy in severe asthmaRichard Beasley, Jonathan Noble, Mark Weatherall
Thorax|March 2, 2023
ICS/formoterol maintenance and reliever therapy: how far beyond asthma?Richard Beasley, Pepa Bruce, Lee Hatter
Trials|May 18, 2018
Pragmatic randomised clinical trials using electronic health records: general practitioner views on a model of a priori consentThomas Hills, Alex Semprini, Richard Beasley
Pediatric Clinics of North America|July 25, 2003
International patterns of the prevalence of pediatric asthma the ISAAC programRichard Beasley, Philippa Ellwood, Innes Asher
The Journal of Allergy and Clinical Immunology|July 9, 2003
What to do at step 3 of the asthma guidelines-increase the dose of inhaled corticosteroids or add a long-acting beta-agonist drug?Matthew Masoli, Shaun Holt, Richard Beasley
Pageof 45

Showing results (51-60 of 443) with videos related to

Sort By:
Pageof 45
Lancet (London, England)|April 18, 2006
New look at the oxyhaemoglobin dissociation curveRichard Beasley, Amanda McNaughton, Geoffrey Robinson
Journal of the Royal Society of Medicine|November 2, 2005
Venous thromboembolism in medical inpatients--the silent epidemic of neglectKyle Perrin, Philip Robinson, Richard Beasley
Expert Review of Respiratory Medicine|October 22, 2013
Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?Mitesh Patel, Janine Pilcher, Richard Beasley
Respirology (Carlton, Vic.)|April 3, 2020
From Osler to personalized medicine in obstructive airways diseaseNethmi Kearns, Ciléin Kearns, Richard Beasley
Journal of Medical Economics|May 16, 2022
A breath of fresh AIR: reducing the carbon footprint of asthmaLee Hatter, Pepa Bruce, Richard Beasley
The European Respiratory Journal|June 20, 2024
The evidence base for ICS/formoterol maintenance and reliever therapy in severe asthmaRichard Beasley, Jonathan Noble, Mark Weatherall
Thorax|March 2, 2023
ICS/formoterol maintenance and reliever therapy: how far beyond asthma?Richard Beasley, Pepa Bruce, Lee Hatter
Trials|May 18, 2018
Pragmatic randomised clinical trials using electronic health records: general practitioner views on a model of a priori consentThomas Hills, Alex Semprini, Richard Beasley
Pediatric Clinics of North America|July 25, 2003
International patterns of the prevalence of pediatric asthma the ISAAC programRichard Beasley, Philippa Ellwood, Innes Asher
The Journal of Allergy and Clinical Immunology|July 9, 2003
What to do at step 3 of the asthma guidelines-increase the dose of inhaled corticosteroids or add a long-acting beta-agonist drug?Matthew Masoli, Shaun Holt, Richard Beasley
Pageof 45